fig5

Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer

Figure 5. Schematic representation of the different types of liposomal drug delivery systems. Conventional liposome (a), PEGylated liposome (b), Ligand-targeted liposome (c), Theragnostic liposome (d)[72] (A); Schematic representation of the different types of liposomes[67] (B); Schematic representation of liposome-based drug delivery system for cancer therapy[68] (C); Schematic illustration for triggered release of hypoxia-responsive liposomal drug delivery system (D)[196]

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/